Cargando…

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab

Detalles Bibliográficos
Autores principales: Megna, Matteo, Genco, Lucia, Noto, Matteo, Patruno, Cataldo, Fabbrocini, Gabriella, Napolitano, Maddalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788048/
https://www.ncbi.nlm.nih.gov/pubmed/36111349
http://dx.doi.org/10.1111/dth.15839
_version_ 1784858660115054592
author Megna, Matteo
Genco, Lucia
Noto, Matteo
Patruno, Cataldo
Fabbrocini, Gabriella
Napolitano, Maddalena
author_facet Megna, Matteo
Genco, Lucia
Noto, Matteo
Patruno, Cataldo
Fabbrocini, Gabriella
Napolitano, Maddalena
author_sort Megna, Matteo
collection PubMed
description
format Online
Article
Text
id pubmed-9788048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-97880482022-12-28 Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab Megna, Matteo Genco, Lucia Noto, Matteo Patruno, Cataldo Fabbrocini, Gabriella Napolitano, Maddalena Dermatol Ther Letters John Wiley & Sons, Inc. 2022-09-23 2022-11 /pmc/articles/PMC9788048/ /pubmed/36111349 http://dx.doi.org/10.1111/dth.15839 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Megna, Matteo
Genco, Lucia
Noto, Matteo
Patruno, Cataldo
Fabbrocini, Gabriella
Napolitano, Maddalena
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title_full Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title_fullStr Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title_full_unstemmed Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title_short Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
title_sort eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788048/
https://www.ncbi.nlm.nih.gov/pubmed/36111349
http://dx.doi.org/10.1111/dth.15839
work_keys_str_mv AT megnamatteo eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab
AT gencolucia eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab
AT notomatteo eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab
AT patrunocataldo eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab
AT fabbrocinigabriella eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab
AT napolitanomaddalena eczematouseruptionafterbrodalumabsuccessfullytreatedwithguselkumabanddupilumab